Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group (Q78106881)
Jump to navigation
Jump to search
scientific article published on 01 July 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group |
scientific article published on 01 July 1999 |
Statements
Cytomegalovirus infections after treatment with daclizumab, an anti IL-2 receptor antibody, for prevention of renal allograft rejection. Roche Study Group (English)
P Hengster
M D Pescovitz
D Hyatt
R Margreiter